| Fabry disease n = 21 | Multiple sclerosis n = 21 | p values |
---|---|---|---|
Sex | Â | Â | 0.76 |
 Female | 12 (57%) | 13 (62%) |  |
 Male | 9 (43%) | 8 (38%) |  |
Age median (IQR, range) | 46 (27; 19–67) | 45 (25; 19–61) | 0.80 |
TIA or Stroke | 2 (8.7%) | 0 | 0.49 |
Cardiomyopathy | 13 (65%) | 0 | < 0.001‡ |
Chronic kidney disease | 13 (65%) | 0 | < 0.001‡ |
Enzyme replacement therapy | 16 (76%) | NA | Â |
Lesion load | Â | Â | 0.27 |
 Singular lesions | 17 (81%) | 14 (67%) |  |
 Beginning confluence | 2 (10%) | 6 (28%) |  |
 Large confluent areas | 2 (10%) | 1 (5%) |  |
MS type | Â | Â | Â |
 RRMS | NA | 13 (62%) |  |
 SPMS | NA | 7 (33%) |  |
 PPMS | NA | 1 (5%) |  |
EDSS median (IQR; range) | NA | 3.5 (3.3; 0–7) |  |
CSF (pos. OCBs and/or intrathecal IG production) | NA | 20 (95%) | Â |